Skip to main content
Top
Published in: Acta Diabetologica 9/2018

Open Access 01-09-2018 | Short Communication

Accelerometer-derived physical activity in those with cardio-metabolic disease compared to healthy adults: a UK Biobank study of 52,556 participants

Authors: Sophie Cassidy, Harley Fuller, Josephine Chau, Michael Catt, Adrian Bauman, Michael I. Trenell

Published in: Acta Diabetologica | Issue 9/2018

Login to get access

Abstract

Aim

Cardio-metabolic disease and physical activity are closely related but large-scale objective studies which measure physical activity are lacking. Using the largest accelerometer cohort to date, we aimed to investigate whether there is an association between disease status and accelerometer variables after a 5-year follow-up.

Methods

106,053 UK Biobank participants wore a wrist-worn GENEactiv monitor. Those with acceptable wear time (> 3 days) were split into 4 cardio-metabolic disease groups based on self-report disease status which was collected 5 ± 1 years prior. Multiple linear regression models were used to investigate associations, controlling for confounders and stratified for gender.

Results

Average daily acceleration was lower in men (‘healthy’-42 ± 15 mg v ‘Type 2 diabetes + cardiovascular disease (CVD)’-31 ± 12 mg) and women (‘healthy’-44 ± 13 mg v ‘Type 2 diabetes + CVD’-31 ± 11 mg) with cardio-metabolic disease and this was consistent across both week and weekend days. Men and women with the worst cardio-metabolic disease perform around half of moderate to vigorous physical activity on a daily basis compared to healthy individuals, and spend almost 7 h per day in 30 min inactivity bouts. Significant associations were seen between cardio-metabolic disease and accelerometer variables 5 years on when controlling for confounders.

Conclusion

In the largest accelerometer cohort to date, there are significant associations between cardio-metabolic disease and physical activity variables after 5 years of follow-up. Triaxial accelerometers provide enhanced measurement opportunities for measuring lifestyle behaviours in chronic disease.
Literature
1.
go back to reference Healy GN et al (2008) Objectively measured sedentary time, physical activity, and metabolic risk: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Diabetes Care 31(2):369–371CrossRefPubMed Healy GN et al (2008) Objectively measured sedentary time, physical activity, and metabolic risk: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab). Diabetes Care 31(2):369–371CrossRefPubMed
2.
go back to reference Rowlands AV et al (2017) Accelerometer-assessed physical activity in epidemiology. Med Sci Sport Exerc 4:1 Rowlands AV et al (2017) Accelerometer-assessed physical activity in epidemiology. Med Sci Sport Exerc 4:1
4.
go back to reference Hildebrand M, Van Hees VT, Hansen BH, Ekelund U (2014) Age group comparability of raw accelerometer output from wrist- and hip-worn monitors. Med Sci Sport Exerc 46(9):1816–1824CrossRef Hildebrand M, Van Hees VT, Hansen BH, Ekelund U (2014) Age group comparability of raw accelerometer output from wrist- and hip-worn monitors. Med Sci Sport Exerc 46(9):1816–1824CrossRef
5.
go back to reference Strath SJ, Holleman RG, Ronis DL, Swartz AM, Richardson CR (2008) Objective physical activity accumulation in bouts and nonbouts and relation to markers of obesity in US adults. Prev Chronic Dis 5(4):A131PubMedPubMedCentral Strath SJ, Holleman RG, Ronis DL, Swartz AM, Richardson CR (2008) Objective physical activity accumulation in bouts and nonbouts and relation to markers of obesity in US adults. Prev Chronic Dis 5(4):A131PubMedPubMedCentral
Metadata
Title
Accelerometer-derived physical activity in those with cardio-metabolic disease compared to healthy adults: a UK Biobank study of 52,556 participants
Authors
Sophie Cassidy
Harley Fuller
Josephine Chau
Michael Catt
Adrian Bauman
Michael I. Trenell
Publication date
01-09-2018
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 9/2018
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-018-1161-8

Other articles of this Issue 9/2018

Acta Diabetologica 9/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.